Global Statin Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Upcoming Report
  • Mar 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Statin Market By Type (Synthetic Statins, Natural Statins), Drug Class (Atorvastatin, Fluvastatin, Lovastatin, Rosuvastatin, Simvastatin, and Pitavastatin), Application (Cardiovascular Diseases, Lifestyle Diseases, Others), End Use (Hospitals, Clinics and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Share Forecast to 2027

Statin Market

Market Analysis and Insights: Global Statin Market

Statin market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market growing at a CAGR of 3.70% in the above-mentioned forecast period. Desk-bound lifestyle and confined to serving in an office rather than in an energetic environment, and lagging physical potential is the essentially defining the market budding growth germination of statin market during the projected time period of 2020 to 2027.

The statin market is expected to gain an exponential growth during the anticipated time phase owning to the declining healthy lifestyle tradition and due to the less indulgence in the physical activities and games. Uplifted defective cholesterol is challenging to handle only on dietary intake and physical exercise. Consequently, statins are prescribed to treat the situation. An expansion in the victims' community experiencing obesity, cardiovascular disorders, and diabetes impels the need for statins crosswise the earth, helping the market to grow. The requirement for efficient therapy to diminish LDL cholesterol is likewise a dominant factor in stimulating the statin market. Cholesterol consciousness drives and technologically forward health administration amenities boost the market for statins. Organizations are extending business proximity across the earth by instituting robust delivery channels particularly in strengthening nations certain features which are driving the statin market exponentially during the forecast period of 2020 to 2027.       

Despite this, an expansion in need for adequate remedy options serves as a major limitation of the statin market. Cultural and commercial agents also hindering the statin business and the aftereffects of statin can work as a restraint of the market.

This statin market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research statin market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Statin Market Scope and Market Size

Statin market is segmented on the basis of type, drug class, application and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the statin market is segmented into natural statins and synthetic statins.
  • On the basis of drug class, the statin market is segmented into atorvastatin, fluvastatin, lovastatin, rosuvastatin, simvastatin, and pitavastatin. Atorvastatin is further sub-segmented as lipitor and others. Fluvastatin is fragmented into lescol, canef, and vastin. Lovastatin is divided into mevacor and others. Pravastatin is categorized into pravacho. Rosuvastatin is classified into crestor. Simvastatin is termed as Zocor. Pitavastatin is phrased as livalo.
  • On the basis of application, the statin market is segmented into cardiovascular diseases, lifestyle diseases, and others. Cardiovascular diseases are further sub-fragmented into heart strokes and attacks. On the basis of lifestyle diseases the market is sub-segmented into obesity, diabetes, and inflammation.
  • On the basis of end use, the statin market is branched into hospitals, clinics and others.

Statin Market Country Level Analysis

Statin market is analysed and market size insights and trends are provided by country, type, drug class, application and end use as referenced above.

The countries covered in the statin market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the statin market owing to expansion in the volume of grown-ups grieving from LDL cholesterol. The acceleration in health supervision investment, and an escalation in the frequency of lifestyle illnesses, is helping to build a strategic statin market in North America. The Asia-Pacific (APAC) is a developing exchange due to accession in degree in obesity and cardiovascular diseases.

The country section of the statin market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Statin market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for statin market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the statin market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Statin Market Share Analysis

Statin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to statin market.

The major players covered in the statin market report are AstraZeneca, Pfizer Inc., Merck Sharp & Dohme Corp., Aurobindo Pharma., Amgen Inc., GlaxoSmithKline plc., Biocon, Concord Biotech, Novartis AG among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Statin Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19